Kindstar Globalgene Technology, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 1,386.59 million compared to CNY 930.67 million a year ago. Net income was CNY 75.46 million compared to net loss of CNY 1,454.43 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0949 compared to basic loss per share from continuing operations of CNY 2.93 a year ago. Diluted earnings per share from continuing operations was CNY 0.0922 compared to diluted loss per share from continuing operations of CNY 2.93 a year ago.